50709-36-9 Usage
Description
2,6-Dichlorophenylhydrazine hydrochloride is an organic compound with the chemical formula C6H6Cl2N2?HCl. It is a white to light yellow powder and is commonly used in the synthesis of various organic compounds, particularly in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
2,6-Dichlorophenylhydrazine hydrochloride is used as a synthetic intermediate for the preparation of various pharmaceutical compounds. Its application is primarily due to its ability to react with different functional groups, facilitating the creation of a wide range of molecules with potential therapeutic properties.
Specifically, it is used in the preparation of 1-(2,6-dichlorophenyl)-4-methyl-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid, ethyl ester, which is a compound with potential applications in the development of new drugs targeting various medical conditions. The use of 2,6-Dichlorophenylhydrazine hydrochloride in this synthesis is attributed to its reactivity and the versatility it provides in constructing the desired molecular structure.
Check Digit Verification of cas no
The CAS Registry Mumber 50709-36-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,7,0 and 9 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 50709-36:
(7*5)+(6*0)+(5*7)+(4*0)+(3*9)+(2*3)+(1*6)=109
109 % 10 = 9
So 50709-36-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H6Cl2N2.ClH/c7-4-2-1-3-5(8)6(4)10-9;/h1-3,10H,9H2;1H
50709-36-9Relevant articles and documents
TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
-
Page/Page column 103; 104, (2014/01/08)
The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.
